In 2025, the Brazil market reported USD 9.54 billion, in terms of market revenue.
Our regional intelligence highlights that the Brazil Infusion Services Market to generate USD 21.96 billion by 2033, registering a CAGR of 11.0% during the forecast period.
Large private oncology networks continue strengthening infusion infrastructure, with São Paulo and Rio de Janeiro accounting for substantial biologic administration volumes.
Brazil’s National Cancer Institute data indicate persistent growth in treated cancer cases, sustaining high systemic therapy demand nationally.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]